# The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis

> **NCT06861179** · PHASE1 · COMPLETED · sponsor: **Zhejiang Cancer Hospital** · enrollment: 40 (actual)

## Conditions studied

- Radiation Pneumonitis

## Interventions

- **DRUG:** The formulation of Compound Phellinus igniarius decoction

## Key facts

- **NCT ID:** NCT06861179
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-22
- **Primary completion:** 2024-12-28
- **Final completion:** 2024-12-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06861179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06861179, "The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06861179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*